What is it about?
This study introduces a new class useful in the traetment of autoimmune disorders like rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus erythematosus, sarcoidosis, focal segmental glomerulosclerosis, Crohn's disease, Behcet's Disease, pemphigus, and ulcerative colitis.
Featured Image
Read the Original
This page is a summary of: New immunosuppressive cyclomyrsinol diterpenes from Euphorbia kopetdaghi Prokh, Natural Product Research, March 2012, Taylor & Francis,
DOI: 10.1080/14786419.2012.671318.
You can read the full text:
Contributors
The following have contributed to this page